Clinical trial Recruiting at 9 sites Phase2; Phase3 Interventional Ages 18 and up

Early double sequential defibrillation for cardiac arrest outside the hospital

Official title: "A Randomized Trial Assessing the Effect of Early Double Sequential Defibrillation With Anterior-posterior and Anterior Lateral Pad Placement and Sequential Defibrillation Compared to Standard Pad Placement and Single Defibrillation in Patients With Out of Hospital Cardiac Arrest With Initial Shockable Rhythm and at Least One Failed Standard Defibrillation"

Run by Karolinska Institutet · NCT07174986 · Data updated 2026-11-12

We test whether using two defibrillators in quick succession after the first failed shock helps adults with out‑of‑hospital cardiac arrest and a shockable rhythm survive more often than continuing standard single shocks.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment916 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations14 sites (Amsterdam and 13 other locations)
StatusRecruiting
StartedSeptember 8, 2025
Main results expectedDecember 31, 2028
Study endsDecember 2029
Registry record updatedFebruary 17, 2026
Trial IDNCT07174986 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with out‑of‑hospital cardiac arrest whose first monitored rhythm is ventricular fibrillation or pulseless ventricular tachycardia and who have received at least one standard anterior‑lateral defibrillation are the intended candidates.

Probably not a fit

Patients with non‑shockable rhythms, pediatric patients, those with known do‑not‑resuscitate orders, or obvious pregnancy are not eligible and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares double sequential defibrillation (two defibrillators delivering shocks in rapid sequence with anterior‑lateral and anterior‑posterior pad placements) to continued standard single‑defibrillator shocks in adults with out‑of‑hospital cardiac arrest who have an initial shockable rhythm and at least one failed standard shock. Patients are enrolled by participating emergency medical services and assigned to either the DSD strategy or standard care during active resuscitation. The primary focus is survival following early application of DSD, with attention to neurologic outcome and termination of ventricular fibrillation. Children, known DNR patients, and those with obvious pregnancy are excluded.

Why it matters

Potential benefit: If successful, this approach could increase survival and improve neurologically intact outcomes for adults with shockable out‑of‑hospital cardiac arrest who don’t respond to an initial defibrillation.

How similar studies have gone: A 2022 prospective cluster randomized trial reported improved survival using DSD or pad‑vector change in refractory VF and ILCOR has endorsed considering DSD after multiple failed shocks, but using DSD immediately after a single failed shock is less tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* OHCA patients with VT/VF at first rhythm analysis and at least one defibrillation performed in standard (A-L) position

Exclusion Criteria:

* Age \< 18 years
* Obvious pregnancy
* Known preexisting Do Not Attempt Resuscitation order

Where it's running

  • Ambulanssjukvården, Region Halland
    Halmstad, Halland County, Sweden
    Recruiting
  • Ambulanssjukvården Region Värmland
    Karlstad, Värmland County, Sweden
    Recruiting
  • Ambulanshelikoptern (HEMS) Västra Götalandsregionen
    Kungälv, Västra Götaland County, Sweden
    Recruiting
  • Sjukvården i väster
    Alingsås, Sweden
    Recruiting
  • Emergency medical services, Södra Älvsborgs Sjukhus, Region Västra Götaland
    Borås, Sweden
    Recruiting
  • Prehospital Intensive Care Unit (PIV) AnOPIVA Östra Sjukhuset/SU
    Gothenburg, Sweden
    Recruiting
Show 8 more locations
  • Shalgrenska University Hospital
    Gothenburg, Sweden
    Recruiting
  • Ambulanssjukvården Skaraborgs Sjukhus, Västra Götalandsregionen (SKAS)
    Skövde, Sweden
    Recruiting
  • Emergency medical services NU-Sjukvården, Region Västra Götaland
    Trollhättan, Sweden
    Recruiting
  • ARREST (AmsteRdam REsuscitation STudies)
    Amsterdam, Netherlands
    Not yet recruiting
  • Centro de Emergencias 061 Andalucía
    Málaga, Andalusia, Spain
    Not yet recruiting
  • Médico Emergencias Osakidetza EMERGENTZIAK
    Bilbao, Baque Country, Spain
    Not yet recruiting
  • Sistema de Emergencias Medicas de Catalunya
    Barcelona, Catalonia, Spain
    Not yet recruiting
  • SUMMA 112 Emergency medical services
    Madrid, Madrid, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: Akil Awad, M.D. Ph.D. — Center for resuscitation Science. Department of clinical sience and education. Södersjukhuset, Karolinksa Institutet, Stockholm, Sweden
  • Study coordinator: Gabriel Riva, M.D. Ph.D
  • Email: gabriel.riva@ki.se
  • Phone: + 47 70 545 20 86

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.